266 related articles for article (PubMed ID: 15812301)
1. Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons.
Ligon LA; LaMonte BH; Wallace KE; Weber N; Kalb RG; Holzbaur EL
Neuroreport; 2005 Apr; 16(6):533-6. PubMed ID: 15812301
[TBL] [Abstract][Full Text] [Related]
2. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
[TBL] [Abstract][Full Text] [Related]
3. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration.
LaMonte BH; Wallace KE; Holloway BA; Shelly SS; Ascaño J; Tokito M; Van Winkle T; Howland DS; Holzbaur EL
Neuron; 2002 May; 34(5):715-27. PubMed ID: 12062019
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic dynein/dynactin function and dysfunction in motor neurons.
Levy JR; Holzbaur EL
Int J Dev Neurosci; 2006; 24(2-3):103-11. PubMed ID: 16406469
[TBL] [Abstract][Full Text] [Related]
5. Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation.
Ström AL; Shi P; Zhang F; Gal J; Kilty R; Hayward LJ; Zhu H
J Biol Chem; 2008 Aug; 283(33):22795-805. PubMed ID: 18515363
[TBL] [Abstract][Full Text] [Related]
6. Effects of ALS-related SOD1 mutants on dynein- and KIF5-mediated retrograde and anterograde axonal transport.
Shi P; Ström AL; Gal J; Zhu H
Biochim Biophys Acta; 2010 Sep; 1802(9):707-16. PubMed ID: 20510358
[TBL] [Abstract][Full Text] [Related]
7. A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration.
Perlson E; Jeong GB; Ross JL; Dixit R; Wallace KE; Kalb RG; Holzbaur EL
J Neurosci; 2009 Aug; 29(31):9903-17. PubMed ID: 19657041
[TBL] [Abstract][Full Text] [Related]
8. Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex.
Zhang F; Ström AL; Fukada K; Lee S; Hayward LJ; Zhu H
J Biol Chem; 2007 Jun; 282(22):16691-9. PubMed ID: 17403682
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the mechanisms involved in motor neuron degeneration in ALS.
Bruijn LI; Miller TM; Cleveland DW
Annu Rev Neurosci; 2004; 27():723-49. PubMed ID: 15217349
[TBL] [Abstract][Full Text] [Related]
10. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice.
Kieran D; Hafezparast M; Bohnert S; Dick JR; Martin J; Schiavo G; Fisher EM; Greensmith L
J Cell Biol; 2005 May; 169(4):561-7. PubMed ID: 15911875
[TBL] [Abstract][Full Text] [Related]
11. Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene.
Warita H; Itoyama Y; Abe K
Brain Res; 1999 Feb; 819(1-2):120-31. PubMed ID: 10082867
[TBL] [Abstract][Full Text] [Related]
12. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
[TBL] [Abstract][Full Text] [Related]
13. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking.
Laird FM; Farah MH; Ackerley S; Hoke A; Maragakis N; Rothstein JD; Griffin J; Price DL; Martin LJ; Wong PC
J Neurosci; 2008 Feb; 28(9):1997-2005. PubMed ID: 18305234
[TBL] [Abstract][Full Text] [Related]
14. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
Chi L; Ke Y; Luo C; Gozal D; Liu R
Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
[TBL] [Abstract][Full Text] [Related]
15. Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration.
Wiesner D; Sinniger J; Henriques A; Dieterlé S; Müller HP; Rasche V; Ferger B; Dirrig-Grosch S; Soylu-Kucharz R; Petersén A; Walther P; Linkus B; Kassubek J; Wong PC; Ludolph AC; Dupuis L
Hum Mol Genet; 2015 Apr; 24(8):2228-40. PubMed ID: 25552654
[TBL] [Abstract][Full Text] [Related]
16. Genetic background effects on disease onset and lifespan of the mutant dynactin p150Glued mouse model of motor neuron disease.
Heiman-Patterson TD; Blankenhorn EP; Sher RB; Jiang J; Welsh P; Dixon MC; Jeffrey JI; Wong P; Cox GA; Alexander GM
PLoS One; 2015; 10(3):e0117848. PubMed ID: 25763819
[TBL] [Abstract][Full Text] [Related]
17. Regulation of dynactin through the differential expression of p150Glued isoforms.
Dixit R; Levy JR; Tokito M; Ligon LA; Holzbaur EL
J Biol Chem; 2008 Nov; 283(48):33611-9. PubMed ID: 18812314
[TBL] [Abstract][Full Text] [Related]
18. Altered Dynein Axonemal Assembly Factor 1 Expression in C-Boutons in Bulbar and Spinal Cord Motor-Neurons in Sporadic Amyotrophic Lateral Sclerosis.
Andrés-Benito P; Povedano M; Torres P; Portero-Otín M; Ferrer I
J Neuropathol Exp Neurol; 2019 May; 78(5):416-425. PubMed ID: 30939186
[TBL] [Abstract][Full Text] [Related]
19. Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease.
Dupuis L; Fergani A; Braunstein KE; Eschbach J; Holl N; Rene F; Gonzalez De Aguilar JL; Zoerner B; Schwalenstocker B; Ludolph AC; Loeffler JP
Exp Neurol; 2009 Jan; 215(1):146-52. PubMed ID: 18952079
[TBL] [Abstract][Full Text] [Related]
20. Amyotrophic lateral sclerosis: all roads lead to Rome.
Gonzalez de Aguilar JL; Echaniz-Laguna A; Fergani A; René F; Meininger V; Loeffler JP; Dupuis L
J Neurochem; 2007 Jun; 101(5):1153-60. PubMed ID: 17250677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
